The DOI matches its Crossref record; 471 of the 471 references it cites were found in a registry or an index.
Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
Open accessAbstract
Alzheimer’s disease (AD) is the most prevalent form of dementia. Despite decades of research following several theoretical and clinical lines, all existing treatments for the disorder are purely symptomatic. AD research has traditionally been focused on neuronal and glial dysfunction. Although there is a wealth of evidence pointing to a significant vascular component in the disease, this angle has been relatively poorly explored. In this review, we consider the various aspects of vascular dysfunction in AD, which has a significant impact on brain metabolism and homeostasis and the clearance of β-amyloid and other toxic metabolites. This may potentially precede the onset of the hallmark pathophysiological and cognitive symptoms of the disease. Pathological changes in vessel haemodynamics, angiogenesis, vascular cell function, vascular coverage, blood-brain barrier permeability and immune cell migration may be related to amyloid toxicity, oxidative stress and apolipoprotein E (APOE) genotype. These vascular deficits may in turn contribute to parenchymal amyloid deposition, neurotoxicity, glial activation and metabolic dysfunction in multiple cell types. A vicious feedback cycle ensues, with progressively worsening neuronal and vascular pathology through the course of the disease. Thus, a better appreciation for the importance of vascular dysfunction in AD may open new avenues for research and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 471
Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia
Kalaria, R. N., Cohen, D. L., Premkumar, D. R. D., Nag, S., LaManna, J. C., & Lust, W. D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00190-9 · Cited by 192
Amyloid efflux transporter expression at the blood-brain barrier declines in normal aging
Silverberg, G. D., Messier, A. A., Miller, M. C., Machan, J. T., Majmudar, S. S., Stopa, E. G., Donahue, J. E., & Johanson, C. E. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181f46e25 · Cited by 191
Niwa, K., Carlson, G. A., & Iadecola, C. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00005 · Cited by 191
Human neutrophils secrete vascular endothelial growth factor
Taichman, N. S., Young, S., Cruchley, A. T., Taylor, P., & Paleolog, E. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.62.3.397 · Cited by 191
Cummings, J. L., Zhong, K., Kinney, J. W., Heaney, C., Moll-Tudla, J., Joshi, A., Pontecorvo, M., Devous, M., Tang, A., & Bena, J. (2016) · Alzheimer's Research & Therapy · doi:10.1186/s13195-016-0173-2 · Cited by 190
A Role for the Chemokine RANTES in Regulating CD8 T Cell Responses during Chronic Viral Infection
Crawford, A., Angelosanto, J. M., Nadwodny, K. L., Blackburn, S. D., & Wherry, E. J. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002098 · Cited by 190
Ferrero, J., Williams, L., Stella, H., Leitermann, K., Mikulskis, A., O'Gorman, J., & Sevigny, J. (2016) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2016.06.002 · Cited by 189 · cited 1×
“Considering these results, as well as the promising safety and tolerability profile of the drug in human AD patients [440,441], it was subsequently advanced to clinical trial.”
BackgroundCardiovascular Risk Factors and Incident Alzheimer Disease: A Systematic Review of the Literature
Purnell, C., Gao, S., Callahan, C. M., & Hendrie, H. C. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318187541c · Cited by 189
DAVIS, K. E. (1992) · PubMed · Cited by 188
Hudry, E., Dashkoff, J., Roe, A. D., Takeda, S., Koffie, R. M., Hashimoto, T., Scheel, M., Spires-Jones, T., Arbel-Ornath, M., Betensky, R., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007000 · Cited by 187
Diminished Glucose Transport in Alzheimer's Disease: Dynamic PET Studies
Jagust, W. J., Seab, J. P., Huesman, R. H., Valk, P. E., Mathis, C. A., Reed, B. R., Coxson, P. G., & Budinger, T. F. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.65 · Cited by 187
Clearance of amyloid β-peptide from brain: transport or metabolism?
Zlokovic, B. V., Yamada, S., Holtzman, D., Ghiso, J., & Frangione, B. (2000) · Nature Medicine · doi:10.1038/77397 · Cited by 186 · cited 1×
“There is considerable discourse over the exact mechanisms involved in these Aβ-induced vasoactive processes [247].”
BackgroundAltered angioarchitecture in selected areas of brains with Alzheimer's disease
Fischer, V. W., Siddiqi, A., & Yusufaly, Y. (1990) · Acta Neuropathologica · doi:10.1007/bf00294246 · Cited by 184
Hultman, K., Strickland, S., & Norris, E. H. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.76 · Cited by 183
de la Torre, J. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180004 · Cited by 183
Cerebral perfusion and oxygenation differences in Alzheimer's disease risk
Fleisher, A. S., Podraza, K. M., Bangen, K. J., Taylor, C., Sherzai, A., Sidhar, K., Liu, T. T., Dale, A. M., & Buxton, R. B. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.01.012 · Cited by 181
Hunter, J. M., Kwan, J., Malek-Ahmadi, M., Maarouf, C. L., Kokjohn, T. A., Belden, C., Sabbagh, M. N., Beach, T. G., & Roher, A. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036893 · Cited by 178
Musiek, E. S., Chen, Y., Korczykowski, M., Saboury, B., Martinez, P. M., Reddin, J. S., Alavi, A., Kimberg, D. Y., Wolk, D. A., Julin, P., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.06.003 · Cited by 178
Belyaev, N. D., Nalivaeva, N. N., Makova, N. Z., & Turner, A. J. (2009) · EMBO reports · doi:10.1038/embor.2008.222 · Cited by 176
Khan, T. A., Shah, T., Prieto, D., Zhang, W., Price, J., Fowkes, G. R., Cooper, J., Talmud, P. J., Humphries, S. E., Sundstrom, J., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt034 · Cited by 176
A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease.
O'Brien, J. T., Eagger, S., Syed, G. M., Sahakian, B. J., & Levy, R. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.12.1182 · Cited by 173
Marco, S., & Skaper, S. D. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.047 · Cited by 172
Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy
Nalivaeva, N. N., & Turner, A. J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14593 · Cited by 172
Mechanisms of microglia accumulation in Alzheimer’s disease: therapeutic implications
Khoury, J. E., & Luster, A. D. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.08.004 · Cited by 171
The GABAergic system as a therapeutic target for Alzheimer's disease
Calvo‐Flores Guzmán, B., Vinnakota, C., Govindpani, K., Waldvogel, H. J., Faull, R. L. M., & Kwakowsky, A. (2018) · Journal of Neurochemistry · doi:10.1111/jnc.14345 · Cited by 171
Self-citationMiners, J. S., Helmond, Z. V., Chalmers, K. A., Wilcock, G. K., Love, S., & Kehoe, P. G. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240463.87886.9a · Cited by 170
Johnson, K. A. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520140035014 · Cited by 170
Yang, S.-P., Bae, D.-G., Kang, H. J., Gwag, B. J., Gho, Y. S., & Chae, C.-B. (2004) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00111-8 · Cited by 169
ICAM-1: Getting a Grip on Leukocyte Adhesion
Long, E. O. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100646 · Cited by 168
A role for human brain pericytes in neuroinflammation
Jansson, D., Rustenhoven, J., Feng, S., Hurley, D., Oldfield, R. L., Bergin, P. S., Mee, E. W., Faull, R. L., & Dragunow, M. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-104 · Cited by 168
Self-citationBeckmann, N., Schuler, A., Mueggler, T., Meyer, E. P., Wiederhold, K., Staufenbiel, M., & Krucker, T. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-24-08453.2003 · Cited by 167
The investigation of Alzheimer's disease with single photon emission tomography.
Burns, A., Philpot, M. P., Costa, D. C., Ell, P. J., & Levy, R. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.2.248 · Cited by 166
Grammas, P., Samany, P. G., & Thirumangalakudi, L. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9105 · Cited by 165
Salloway, S., Honigberg, L. A., Cho, W., Ward, M. E., Friesenhahn, M. J., Brunstein, F., Quartino, A. L., Clayton, D., Mortensen, D. L., Bittner, T., et al. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0424-5 · Cited by 165
Sagare, A. P., Deane, R., & Zloković, B. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.008 · Cited by 164
Jobst, K. A., Smith, A. D., Barker, C. S., Wear, A., King, E. M., Smith, A., Anslow, P. A., Molyneux, A. J., Shepstone, B. J., & Soper, N. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.190 · Cited by 163
RANTES upregulation in the Alzheimer's disease brain: A possible neuroprotective role
Tripathy, D., Thirumangalakudi, L., & Grammas, P. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.03.009 · Cited by 161
Kalback, W., Esh, C., Castaño, E. M., Rahman, A., Kokjohn, T., Luehrs, D. C., Sue, L., Cisneros, R., Gerber, F., Richardson, C., et al. (2004) · Neurological Research · doi:10.1179/016164104225017668 · Cited by 160
Balabanov, R. D., Beaumont, T., & Dore‐Duffy, P. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990301)55:5<578::aid-jnr5>3.0.co;2-e · Cited by 157
Lannfelt, L., Möller, C., Basun, H., Osswald, G., Sehlin, D., Satlin, A., Logovinsky, V., & Gellerfors, P. (2014) · Alzheimer s Research & Therapy · doi:10.1186/alzrt246 · Cited by 154
Evidence of angiogenic vessels in Alzheimer’s disease
Desai, B. S., Schneider, J. A., Li, J.-L., Carvey, P. M., & Hendey, B. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0226-9 · Cited by 153
Jaeger, L. B., Dohgu, S., Hwang, M. C., Farr, S. A., Murphy, M. P., Fleegal, M. A., Lynch, J. L., Robinson, S. M., Niehoff, M. L., Johnson, S. N., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1074 · Cited by 153
Transforming Growth Factor-β1 Potentiates Amyloid-β Generation in Astrocytes and in Transgenic Mice
Lesné, S., Docagne, F., Gabriel, C., Liot, G., Lahiri, D. K., Buée, L., Plawinski, L., Delacourte, A., MacKenzie, E. T., Buisson, A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300819200 · Cited by 151
The vascular factor in Alzheimer's disease: A study in Golgi technique and electron microscopy
Baloyannis, S. J., & Baloyannis, I. S. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.07.010 · Cited by 150
Davis‐Salinas, J., Saporito‐Irwin, S. M., Cotman, C. W., & Van Nostrand, W. E. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020931.x · Cited by 150
Religa, P., Cao, R., Religa, D., Xue, Y., Bogdanović, N., Westaway, D. A., Marti, H. H., Winblad, B. G., & Cao, Y. (2013) · Scientific Reports · doi:10.1038/srep02053 · Cited by 150
Mixed dementia: A review of the evidence
Custodio, N., Montesinos, R., Lira, D., Herrera-Pérez, E., Bardales, Y., & Valeriano-Lorenzo, L. (2017) · Dementia & Neuropsychologia · doi:10.1590/1980-57642016dn11-040005 · Cited by 148 · cited 3×
“Indeed, it has been suggested that the majority of older patients present with a mixed-dementia with characteristics of both conditions [18].”
BackgroundInfluentialInhibition of Angiogenesis by Aβ Peptides
Paris, D., Townsend, K., Quadros, A., Humphrey, J., Sun, J., Brem, S., Wotoczek-Obadia, M., DelleDonne, A., Patel, N., Obregon, D. F., et al. (2004) · Angiogenesis · doi:10.1023/b:agen.0000037335.17717.bf · Cited by 148
Cholinergic modulation of the cortical microvascular bed
Hamel, É. (2004) · Progress in brain research · doi:10.1016/s0079-6123(03)45012-7 · Cited by 148
Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease
Jellinger, K. A., & Attems, J. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.018 · Cited by 148
Soluble Low Density Lipoprotein Receptor-related Protein (LRP) Circulates in Human Plasma
Quinn, K., Grimsley, P. G., Dai, Y.-P., Tapner, M. J., Chesterman, C. N., & Owensby, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23946 · Cited by 148
A morphometric study of the blood-brain barrier in Alzheimer's disease.
Stewart, P. A., Hayakawa, K., Akers, M.-A., & Vinters, H. V. (1992) · PubMed · Cited by 148
Thickening of the basement membrane of cortical capillaries in Alzheimer's disease
Mancardi, G., Perdelli, F., Rivano, C., Leonardi, A., & Bugiani, O. (1980) · Acta Neuropathologica · doi:10.1007/bf00692225 · Cited by 147
ACTIVATED HUMAN NEUTROPHILS EXPRESS VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF)
Webb, N. J. A., Myers, C. R., Watson, C. J., Bottomley, M. J., & Brenchley, P. E. (1998) · Cytokine · doi:10.1006/cyto.1997.0297 · Cited by 145
Clementi, M. E., Marini, S., Coletta, M., Orsini, F., Giardina, B., & Misiti, F. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.041 · Cited by 144
APOE genotype and cognitive decline in a middle-aged cohort
Blair, C. K., Folsom, A. R., Knopman, D. S., Bray, M. S., Mosley, T. H., & Boerwinkle, E. (2005) · Neurology · doi:10.1212/01.wnl.0000149643.91367.8a · Cited by 143
Unique and shared inflammatory profiles of human brain endothelia and pericytes
Smyth, L. C. D., Rustenhoven, J., Park, T., Schweder, P. M., Jansson, D., Heppner, P. A., O’Carroll, S. J., Mee, E. W., Faull, R. L. M., Curtis, M. A., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1167-8 · Cited by 142
Self-citationBlanc, E. M., Toborek, M., Mark, R. J., Hennig, B., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68051870.x · Cited by 141
Hemodynamic Consequences of Deformed Microvessels in the Brain in Alzheimer's Disease
de la Torre, J. C. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48462.x · Cited by 140
Wilhelmus, M. M. M., Otte-Höller, I., van Triel, J. J. J., Veerhuis, R., Maat-Schieman, M. L. C., Bu, G., de Waal, R. M. W., & Verbeek, M. M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070050 · Cited by 138
Vinters, H. V., Secor, D. L., Read, S. L., Frazee, J. G., Tomiyasu, U., Stanley, T. M., Ferreiro, J. A., & Akers, M.-A. (1994) · Ultrastructural Pathology · doi:10.3109/01913129409023202 · Cited by 138
A Review of String Vessels or Collapsed, Empty Basement Membrane Tubes
Brown, W. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100219 · Cited by 136
Cerebral perfusion in the predementia stages of Alzheimer’s disease
Binnewijzend, M. A. A., Benedictus, M. R., Kuijer, J. P. A., van der Flier, W. M., Teunissen, C. E., Prins, N. D., Wattjes, M. P., van Berckel, B. N. M., Scheltens, P., & Barkhof, F. (2015) · European Radiology · doi:10.1007/s00330-015-3834-9 · Cited by 135
Alexopoulos, P., Sorg, C., Förschler, A., Grimmer, T., Σκώκου, Μ., Wohlschläger, A. M., Perneczky, R., Zimmer, C., Kurz, A., & Preibisch, C. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0226-2 · Cited by 135
SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele.
Lehtovirta, M., Soininen, H. S., Laakso, M. P., Partanen, K. P. L., Helisalmi, S., Mannermaa, A., Ryynänen, M., Kuikka, J. T., Hartikainen, P. H., & Riekkinen, P. J. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.60.6.644 · Cited by 135
Carpentier, M., Robitaille, Y., DesGroseillers, L., Boileau, G., & Marcinkiewicz, M. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.10.849 · Cited by 135
Hajjar, I. M., Brown, L., Mack, W. J., & Chui, H. (2012) · Archives of Neurology · doi:10.1001/archneurol.2012.1010 · Cited by 134
Grammas, P., & Ovase, R. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61105-4 · Cited by 133
Maier, F. C., Wehrl, H. F., Schmid, A. M., Mannheim, J. G., Wiehr, S., Lerdkrai, C., Calaminus, C., Stahlschmidt, A., Ye, L., Burnet, M. W. M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3734 · Cited by 132
Low serum VEGF levels are associated with Alzheimer's disease
Mateo, I., Llorca, J., Infante, J., Rodríguez‐Rodríguez, E., Fernández‐Viadero, C., Peña, N., Berciano, J., & Combarros, O. (2006) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2006.00775.x · Cited by 132
Brain capillary pericytes contribute to the immune defense in response to cytokines or LPS in vitro
Pieper, C., Marek, J. J., Unterberg, M., Schwerdtle, T., & Galla, H. (2014) · Brain Research · doi:10.1016/j.brainres.2014.01.004 · Cited by 132
Perlmutter, L. S., Chui, H. C., Saperia, D., & Athanikar, J. N. (1990) · Brain Research · doi:10.1016/0006-8993(90)91111-s · Cited by 131
Immune Reactions Associated With Cerebral Amyloid Angiopathy
Yamada, M., Itoh, Y., Shintaku, M., Kawamura, J., Jensson, Ó., Thorsteinsson, L., Suematsu, N., Matsushita, M., & Otomo, E. (1996) · Stroke · doi:10.1161/01.str.27.7.1155 · Cited by 131
Knopman, D. S., Jack, C. R., Wiste, H. J., Lundt, E. S., Weigand, S. D., Vemuri, P., Lowe, V. J., Kantarci, K., Gunter, J. L., Senjem, M. L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.006 · Cited by 131
Comparison of CT, MR, and PET in Alzheimer's dementia and normal aging.
Fazekas, F., Alavi, A. A., Chawluk, J. B., Zimmerman, R. A., Hackney, D. B., Bilaniuk, L. T., Rosen, M. P., Alves, W. M., Hurtig, H. I., & Jamieson, D. G. (1989) · PubMed · Cited by 129
Glut1/SLC2A1 is crucial for the development of the blood‐brain barrier in vivo
Zheng, P., Romme, E., van der Spek, P. J., Dirven, C. M. F., Willemsen, R., & Kros, J. M. (2010) · Annals of Neurology · doi:10.1002/ana.22318 · Cited by 129
Spuch, C., Antequera, D., Portero, A., Orive, G., Hernández, R. M., Molina, J. A., Bermejo‐Pareja, F., Pedraz, J. L., & Carro, E. (2010) · Biomaterials · doi:10.1016/j.biomaterials.2010.03.042 · Cited by 129
Tariot, P. N., Lopera, F., Langbaum, J. B., Thomas, R. G., Hendrix, S., Schneider, L. S., Rios‐Romenets, S., Giraldo, M., Acosta, N., Tobon, C., et al. (2018) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2018.02.002 · Cited by 128
Boven, L. A., Middel, J., Verhoef, J., Groot, C. J. A. D., & Nottet, H. S. L. M. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2000.00255.x · Cited by 128
Alzheimer disease and risk of stroke: A population-based cohort study
Chi, N., Chien, L., Ku, H., Hu, C., & Chiou, H. (2013) · Neurology · doi:10.1212/wnl.0b013e31828250af · Cited by 128
Paris, D., Humphrey, J., Quadros, A., Patel, N., Crescentini, R., Crawford, F., & Mullan, M. (2003) · Neurological Research · doi:10.1179/016164103101201940 · Cited by 127
Interaction of Age and APOE Genotype on Cerebral Blood Flow at Rest
Wierenga, C. E., Clark, L. R., Dev, S. I., Shin, D. D., Jurick, S. M., Rissman, R. A., Liu, T. T., & Bondi, M. W. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121897 · Cited by 127
Shinohara, M., Sato, N., Kurinami, H., Takeuchi, D., Takeda, S., Shimamura, M., Yamashita, T., Uchiyama, Y., Rakugi, H., & Morishita, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.102277 · Cited by 126
Olichney, J., Hansen, L. A., Hofstetter, C. R., Lee, J. H., Katzman, R., & Thal, L. J. (2000) · Archives of Neurology · doi:10.1001/archneur.57.6.869 · Cited by 125
Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid deposits
Frautschy, S. A., Yang, F., Calderón, L., & Cole, G. M. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02073-x · Cited by 125
4D flow MRI for intracranial hemodynamics assessment in Alzheimer’s disease
Rivera‐Rivera, L. A., Turski, P. A., Johnson, K. M., Hoffman, C. A., Berman, S. E., Kilgas, P., Rowley, H. A., Carlsson, C. M., Johnson, S. C., & Wieben, O. E. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x15617171 · Cited by 125
Effect of Oxidative Stress on the Junctional Proteins of Cultured Cerebral Endothelial Cells
Krizbai, I. A., Bauer, H., Bresgen, N., Eckl, P., Farkas, A. E., Szatmari, E. M., Traweger, A., Wejksza, K., & Bauer, H. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-004-1378-7 · Cited by 123
Gray, C. W., & Patel, A. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90037-p · Cited by 123
Apolipoprotein E and Atherosclerosis: Beyond Lipid Effect
Davignon, J. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000154570.50696.2c · Cited by 121
Hunter, R., McLuskie, R., Wyper, D., Patterson, J. C., CHRISTIE, J. E., Brooks, D. N., McCulloch, J., Fink, G., & Goodwin, G. M. (1989) · Psychological Medicine · doi:10.1017/s0033291700005560 · Cited by 120
Halliday, M. R., Pomara, N., Sagare, A. P., Mack, W. J., Frangione, B., & Zlokovic, B. V. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3841 · Cited by 119
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer’s Disease and Related Tauopathies
Castillo-Carranza, D. L., Nilson, A. N., Van Skike, C. E., Jahrling, J. B., Patel, K., Garach, P., Gerson, J. E., Sengupta, U., Abisambra, J., Nelson, P., et al. (2017) · Aging and disease · doi:10.14336/ad.2017.0112 · Cited by 118
Angiogenic proteins are expressed by brain blood vessels in Alzheimer's disease
Thirumangalakudi, L., Samany, P. G., Owoso, A., Wiskar, B., & Grammas, P. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-10114 · Cited by 117
Impairment of the Blood–Nerve and Blood–Brain Barriers in Apolipoprotein E Knockout Mice
Fullerton, S. M., Shirman, G. A., Strittmatter, W. J., & Matthew, W. D. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7631 · Cited by 117
Central Angiotensin II Stimulation Promotes β Amyloid Production in Sprague Dawley Rats
Zhu, D., Shi, J., Zhang, Y., Wang, B., Liu, W., Chen, Z., & Tong, Q. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016037 · Cited by 117
Suo, Z., Tan, J., Placzek, A., Crawford, F., Fang, C., & Mullan, M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00780-x · Cited by 116
Association of Alzheimer disease pathology with abnormal lipid metabolism: The Hisayama Study
Matsuzaki, T., Sasaki, K., Hata, J., Hirakawa, Y., Fujimi, K., Ninomiya, T., Suzuki, S. O., Kanba, S., Kiyohara, Y., & Iwaki, T. (2011) · Neurology · doi:10.1212/wnl.0b013e31822e145d · Cited by 115
Lipid Binding-induced Conformational Change in Human Apolipoprotein E
Saito, H., Dhanasekaran, P., Baldwin, F., Weisgraber, K. H., Lund-Katz, S., & Phillips, M. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106337200 · Cited by 113
Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease
Salloway, S., Gur, T., Berzin, T., Zipser, B., Correia, S., Hovanesian, V, Fallon, J., Kuo-Leblanc, V, Glass, D., Hulette, C., et al. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00288-5 · Cited by 113
Zamolodchikov, D., & Strickland, S. (2012) · Blood · doi:10.1182/blood-2011-11-389668 · Cited by 113
Characteristics of thein VitroVasoactivity of β-Amyloid Peptides
Crawford, F., Suo, Z., Fang, C., & Mullan, M. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6743 · Cited by 112
Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease.
Nakano, S., Asada, T., Matsuda, H., Uno, M., & Takasaki, M. (2001) · PubMed · Cited by 112
A Population-Based Study on Blood Pressure and Brain Atrophy in 85-Year-Olds
Skoog, I. G., Andreasson, L., Landahl, S., & Lernfelt, B. (1998) · Hypertension · doi:10.1161/01.hyp.32.3.404 · Cited by 112
Cesaris, P. D., Starace, D., Starace, G., Filippini, A., Stefanini, M., & Ziparo, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28978 · Cited by 112
Glial Cells - The Key Elements of Alzheimers Disease
Džamba, D., Harantová, L., Butenko, O., & Anděrová, M. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160129095924 · Cited by 112
Intracranial atherosclerosis and dementia: The Atherosclerosis Risk in Communities (ARIC) Study
Dearborn, J. L., Zhang, Y., Qiao, Y., Suri, M. F. K., Liu, L., Gottesman, R. F., Rawlings, A. M., Mosley, T. H., Alonso, Á., Knopman, D. S., et al. (2017) · Neurology · doi:10.1212/wnl.0000000000003837 · Cited by 112
Aβ peptide immunization restores blood‐brain barrier integrity in Alzheimer disease
Dickstein, D. L., Biron, K. E., Ujiie, M., Pfeifer, C. G., Jeffries, A. R., & Jefferies, W. A. (2006) · The FASEB Journal · doi:10.1096/fj.05-3956com · Cited by 111 · cited 2×
“Aβ has been shown to repair BBB permeability and immunization prior to AD symptom-onset appears to prevent aberrant angiogenesis and the impairment of BBB permeability [302,303].”
BackgroundCerebrovascular Degeneration Is Related to Amyloid‐β Protein Deposition in Alzheimer's Disease a
Kalaria, R. N. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48478.x · Cited by 110
Oh, H., Habeck, C. G., Madison, C. M., & Jagust, W. J. (2012) · Human Brain Mapping · doi:10.1002/hbm.22173 · Cited by 109
Okonkwo, O. C., Xu, G., Oh, J. M., Dowling, N. M., Carlsson, C. M., Gallagher, C. L., Birdsill, A. C., Palotti, M. L., Wharton, W., Hermann, B. P., et al. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhs381 · Cited by 109
Gabin, J. M., Tambs, K., Saltvedt, I. T., Sund, E. R., & Holmen, J. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0262-x · Cited by 107
Kallmann, B. A. (2000) · Brain · doi:10.1093/brain/123.4.687 · Cited by 106
Subasinghe, S., Unabia, S. E., Barrow, C. J., Mok, S. S., Aguilar, M., & Small, D. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01552.x · Cited by 104
Reduced temporal lobe blood flow in alzheimer's disease
Eberling, J. L., Jagust, W., Reed, B., & Baker, M. G. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90076-a · Cited by 104
Wang, P., Xie, Z., Guo, Y., Zhao, C., Jiang, H., Song, Y., Zhu, Z., Lai, C., Xu, S., & Bi, J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.07.003 · Cited by 104
Brain Endothelial Cells Synthesize Neurotoxic Thrombin in Alzheimer’s Disease
Yin, X., Wright, J., Wall, T., & Grammas, P. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090406 · Cited by 104
Is RAGE Still A Therapeutic Target For Alzheimer’s Disease?
Deane, R. J. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.51 · Cited by 104
Thal, D. R., Papassotiropoulos, A., Saido, T. C., Griffin, W. S. T., Mrak, R. E., Kölsch, H., Tredici, K. D., Attems, J., & Ghebremedhin, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0707-9 · Cited by 103
Nobili, F. M., Koulibaly, M., Vitali, P., Migneco, O., Mariani, G., Ebmeier, K. P., Pupi, A., Robert, P. H., Rodriguez, G., & Darcourt, J. (2002) · PubMed · Cited by 103
Pieper, C., Pieloch, P., & Galla, H. (2013) · Brain Research · doi:10.1016/j.brainres.2013.05.047 · Cited by 103
Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia
Tripathy, D., Sanchez, A. C., Yin, X., Luo, J., Martinez, J. M., & Grammas, P. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00019 · Cited by 103
Verbeek, M. M., Westphal, J. R., Ruiter, D. J., & de Waal, R. M. W. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.11.5876 · Cited by 103
Gonzalez, R. G., Fischman, A. J., Guimarães, A. R., Carr, C. A., Stern, C. E., Halpern, E. F., Growdon, J. H., & Rosen, B. R. (1995) · PubMed · Cited by 103
Association of APOE genotype with carotid atherosclerosis in men and women
Elosua, R., Ordovas, J. M., Cupples, L. A., Fox, C. S., Polak, J. F., Wolf, P. A., D’Agostino, R. A., & O’Donnell, C. J. (2004) · Journal of Lipid Research · doi:10.1194/jlr.m400114-jlr200 · Cited by 101
Increased levels of hemoglobin-derived and other peptides in Alzheimer's disease cerebellum
Slemmon, J. R., Hughes, C., Ga, C., & Flood, D. G. (1994) · Journal of Neuroscience · doi:10.1523/jneurosci.14-04-02225.1994 · Cited by 101
Patel, N. S., Mathura, V. S., Bachmeier, C. J., Beaulieu‐Abdelahad, D., Laporte, V., Weeks, O. I., MULLAN, M. J., & Paris, D. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06426.x · Cited by 100
Clearance of Amyloid-Beta in Alzheimer’s Disease: Shifting the Action Site from Center to Periphery
Liu, Y.-H., Wang, Y.-R., Xiang, Y., Zhou, H.-D., Giunta, B., Mañucat-Tan, N. B., Tan, J., Zhou, X.-F., & Wang, Y.-J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8694-9 · Cited by 99
Cerebrospinal fluid neprilysin is reduced in prodromal Alzheimer's disease
Maruyama, M., Higuchi, M., Takaki, Y., Matsuba, Y., Tanji, H., Nemoto, M., Tomita, N., Matsui, T., Iwata, N., Mizukami, H., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20494 · Cited by 99
Claassen, J. A. H. R., & Jansen, R. W. M. M. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.3.267 · Cited by 99
Horwood, N., & Davies, D. C. (1994) · Virchows Archiv · doi:10.1007/bf00193951 · Cited by 97
Tian, J., Shi, J., Bailey, K. L., & Mann, D. M. A. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2003.00510.x · Cited by 97
SPECT Study of Regional Cerebral Blood Flow in Alzheimer Disease
Bonte, F. J., Ross, E. D., Chehabi, H. H., & Devous, M. D. (1986) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-198607000-00005 · Cited by 97
Huang, L. K., Jia, J., & Liu, R. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.06.031 · Cited by 97
Kim, S. M., Kim, M. J., Rhee, H. Y., Ryu, C., Kim, E. J., Petersen, E. T., & Jahng, G. (2012) · Neuroradiology · doi:10.1007/s00234-012-1077-x · Cited by 97
Vascular changes in senile brains
HASSLER, O. (1965) · Acta Neuropathologica · doi:10.1007/bf00689161 · Cited by 96
Rivera‐Rivera, L. A., Schubert, T. B., Turski, P. A., Johnson, K. M., Berman, S. E., Rowley, H. A., Carlsson, C. M., Johnson, S. C., & Wieben, O. E. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16661340 · Cited by 96
Matsumoto, J., Takata, F., Machida, T., Takahashi, H., Soejima, Y., Funakoshi, M., Futagami, K., Yamauchi, A., Dohgu, S., & Kataoka, Y. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.06.052 · Cited by 95
Adjusting the compass: new insights into the role of angiogenesis in Alzheimer’s disease
Jefferies, W. A., Price, K. A., Biron, K. E., Fenninger, F., Pfeifer, C. G., & Dickstein, D. L. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt230 · Cited by 95
The cerebrovascular role of the cholinergic neural system in Alzheimer's disease
van Beek, A. H. E. A., & Claassen, J. A. H. R. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.12.047 · Cited by 94
Ishii, K., Sasaki, M., Yamaji, S., Sakamoto, S., Kitagaki, H., & Mori, E. (1997) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00841407 · Cited by 94
Kalaria, R. N., Sromek, S. M., Grahovac, I., & Harik, S. I. (1992) · Brain Research · doi:10.1016/0006-8993(92)91193-i · Cited by 94
Rozzini, L., Chilovi, B. V., Bertoletti, E., Conti, M., Rio, I. D., Trabucchi, M., & Padovani, A. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1523 · Cited by 93
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
Currais, A. J. M., Quehenberger, O., Armando, A. M., Daugherty, D., Maher, P., & Schubert, D. A. (2016) · npj Aging and Mechanisms of Disease · doi:10.1038/npjamd.2016.12 · Cited by 90
Effects of blood pressure and lipid lowering on cognition: Results from the HOPE-3 study
Bosch, J., O'Donnell, M. J., Swaminathan, B., Lonn, E., Sharma, M., Dagenais, G. R., Díaz, R., Khunti, K., Lewis, B. S., Avezum, Á., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007174 · Cited by 88
Candela, P., Saint‐Pol, J., Kuntz, M., Boucau, M., Lamartinière, Y., Gosselet, F., & Fénart, L. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.047 · Cited by 87
Gasic‐Milenkovic, J., Dukic‐Stefanovic, S., Deuther‐Conrad, W., Gärtner, U., & Münch, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02506.x · Cited by 87
Fossati, S., Cam, J. A., Meyerson, J. L., Mezhericher, E., Romero, I. A., Couraud, P., Weksler, B. B., Ghiso, J. A., & Rostagno, A. A. (2009) · The FASEB Journal · doi:10.1096/fj.09-139584 · Cited by 87
A damaged microcirculation contributes to neuronal cell death in Alzheimer’s disease☆
Grammas, P. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00102-0 · Cited by 86
Metter, E. J., Riege, W. H., Kameyama, M., Kuhl, D. E., & Phelps, M. E. (1984) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1984.74 · Cited by 86
Association of hypometabolism and amyloid levels in aging, normal subjects
Lowe, V. J., Weigand, S. D., Senjem, M. L., Vemuri, P., Jordan, L. G., Kantarci, K., Boeve, B. F., Jack, C. R., Knopman, D. S., & Petersen, R. C. (2014) · Neurology · doi:10.1212/wnl.0000000000000467 · Cited by 86
Microvessels from Alzheimer's Disease Brains Kill Neurons in Vitro
Grammas, P., Moore, P., & Weigel, P. H. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65280-7 · Cited by 85
Evidence to Consider Angiotensin II Receptor Blockers for the Treatment of Early Alzheimer’s Disease
Saavedra, J. M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0327-y · Cited by 84
Ó’Caoimh, R., Healy, L. O., Gao, Y., Svendrovski, A., Kerins, D. M., Eustace, J. A., Kehoe, P. G., Guyatt, G. H., & Molloy, D. W. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-131694 · Cited by 83
Dobbie, M. S., Hurst, R. D., Klein, N. J., & Surtees, R. A. H. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01436-5 · Cited by 82
Amyloid-beta immunotherapy: the hope for Alzheimer disease?
Barrera-Ocampo, A. A., & Lopera, F. J. (2016) · Colombia medica · doi:10.25100/cm.v47i4.2640 · Cited by 81
Uchihara, T., Akiyama, H., Kondo, H., & Ikeda, K. (1997) · Stroke · doi:10.1161/01.str.28.10.1948 · Cited by 79
Amyloid‐beta 1‐40 is associated with alterations in NG2+ pericyte population ex vivo and in vitro
Schultz, N., Brännström, K., Byman, E., Moussaud, S., Nielsen, H. M., Bank, T. N. B., Olofsson, A., & Wennström, M. (2018) · Aging Cell · doi:10.1111/acel.12728 · Cited by 79
Yang, D.-S., Small, D. H., Seydel, U., Smith, J. D., Hallmayer, J., Gandy, S. E., & Martins, R. N. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00561-2 · Cited by 76
Łojkowska, W., Ryglewicz, D., Jedrzejczak, T., Kotapka-Minc, S., Jakubowska, T., Sienkiewicz‐Jarosz, H., & Bochyńska, A. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(03)00229-6 · Cited by 76
Alzheimer disease: Plaques, tangles, and the basal forebrain
Whitehouse, P. J., Struble, R. G., Clark, A. W., & Price, D. L. (1982) · Annals of Neurology · doi:10.1002/ana.410120517 · Cited by 75
Endothelial cell regulation of matrix metalloproteinases
Haas, T. L. (2005) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y04-120 · Cited by 75
Comparative Evolution of Alzheimer Disease, Vascular Dementia, and Mixed Dementia
Bowler, J. V., Eliasziw, M., Steenhuis, R., Munoz, D. G., Fry, R., Merskey, H., & Hachinski, V. C. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550180021007 · Cited by 75
Longitudinal Cerebral Blood Flow and Amyloid Deposition: An Emerging Pattern?
Sojkova, J., Beason‐Held, L. L., Zhou, Y., An, Y., Kraut, M. A., Ye, W., Ferrucci, L., Mathis, C. A., Klunk, W. E., Wong, D. F., et al. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.051946 · Cited by 75
A New Paradigm for the Treatment of Alzheimer's Disease: Targeting Vascular Activation
Grammas, P., Martinez, J. M., Sanchez, A. C., Yin, X., Riley, J., Gay, D., Desobry, K., Tripathy, D., Luo, J., Evola, M., et al. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-2014-132057 · Cited by 74
Davis-Salinas, J., & Nostrand, W. E. V. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.36.20887 · Cited by 74
Rosenbaum, D. H., Mattina, A., Koch, E., et al. (2016) · Journal of Hypertension · doi:10.1097/hjh.0000000000000894 · Cited by 74
Zaheer, A., Zaheer, S. A., Thangavel, R., Wu, Y., Sahu, S. K., & Yang, B. (2008) · Brain Research · doi:10.1016/j.brainres.2008.02.093 · Cited by 73
Astrocyte responses to injury: VEGF simultaneously modulates cell death and proliferation
Schmid-Brunclik, N., Taboada, C. B., Antoniou, X., Gassmann, M., & Ogunshola, O. O. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00536.2007 · Cited by 73
Holman, B. L., Johnson, K. A., Gerada, B., Carvalho, P. A., & Satlin, A. (1992) · PubMed · Cited by 73
Ylilauri, M. P., Voutilainen, S., Lönnroos, E., Mursu, J., Virtanen, H. E., Koskinen, T. T., Salonen, J. T., Tuomainen, T., & Virtanen, J. K. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.116.146753 · Cited by 73
Ayres-Sander, C. E., Lauridsen, H. M., Maier, C. L., Sava, P., Pober, J. S., & Gonzalez, A. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060025 · Cited by 72
Hypoxia/aglycemia increases endothelial permeability: role of second messengers and cytoskeleton
Park, J. H., Okayama, N., Gute, D. C., Krsmanovic, A., Battarbee, H. D., & Alexander, J. (1999) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1999.277.6.c1066 · Cited by 71
APP Regulates Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Manocha, G. D., Floden, A. M., Rausch, K., Kulas, J. A., McGregor, B. A., Rojanathammanee, L., Puig, K. L., Puig, K. L., Karki, S., Nichols, M. R., et al. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.4654-15.2016 · Cited by 71
Amara, F., Junaid, A., Clough, R. R., & Liang, B. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00158-8 · Cited by 70
Volk, T. J., Hensel, M., Schuster, H., & Kox, W. J. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007059616914 · Cited by 68
Longitudinal SPECT study in Alzheimer's disease: relation to apolipoprotein E polymorphism
Lehtovirta, M., Kuikka, J. T., Helisalmi, S., Hartikainen, P. H., Mannermaa, A., Ryynänen, M., Riekkinen, P., & Soininen, H. S. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.64.6.742 · Cited by 68
Soluble β-amyloid peptides mediate vasoactivity via activation of a pro-inflammatory pathway
Paris, D., Town, T., Mori, T., Parker, T. A., Humphrey, J., & MULLAN, M. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00111-6 · Cited by 66
Alzheimer’s-Related Peptide Amyloid-β Plays a Conserved Role in Angiogenesis
Cameron, D. J., Galvin, C. J., Alkam, T., Sidhu, H., Ellison, J., Luna, S., & Ethell, D. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039598 · Cited by 66
Ebmeier, K. P., Hunter, R., Curran, S., Dougall, N., Murray, C. L., Wyper, D., Patterson, J. C., Hanson, M. T., Siegfried, K., & Goodwin, G. M. (1992) · Psychopharmacology · doi:10.1007/bf02245293 · Cited by 66
Corder, E. H., Jelić, V., Basun, H., Lannfelt, L., Valind, S., Winblad, B. G., & Nordberg, A. K. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550150035013 · Cited by 65
α2-Macroglobulin-Mediated Degradation of Amyloid β1–42: A Mechanism to Enhance Amyloid β Catabolism
Lauer, D., Reichenbach, A., & Birkenmeier, G. (2001) · Experimental Neurology · doi:10.1006/exnr.2000.7569 · Cited by 65
Imaging local brain function with emission computed tomography.
KUHL, D. E. (1984) · Radiology · doi:10.1148/radiology.150.3.6607481 · Cited by 64
Abnormal blood vessel development in mice lacking presenilin-1
Nakajima, M., Yuasa, S., Ueno, M., Takakura, N., Koseki, H., & Shirasawa, T. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(03)00064-9 · Cited by 63
Expression of CAP37, a Novel Inflammatory Mediator, in Alzheimer's Disease
Pereira, H. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00118-2 · Cited by 62
Ultrastructural studies of amyloid fibrils and senile plaques in human brain
Miyakawa, T., Katsuragi, S., Watanabe, K., Shimoji, A., & Ikeuchi, Y. (1986) · Acta Neuropathologica · doi:10.1007/bf00686073 · Cited by 62
Expression of CAP37, a Novel Inflammatory Mediator, in Alzheimer's Disease
Pereira, H. A., Kumar, P., & Grammas, P. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00118-2 · Cited by 62
Barritt, J. D., & Viles, J. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.684084 · Cited by 62
Strazielle, N., Ghersi‐Egea, J., Ghiso, J. A., Dehouck, M., Frangione, B., Patlak, C. S., Fenstermacher, J. D., & Gorevic, P. D. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.1.29 · Cited by 60
Blood-Brain Barrier Integrity and Clearance of Amyloid-β from the BBB
Cockerill, I., Oliver, J.-A. N., Xu, H., Fu, B. M., & Zhu, D. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-96445-4_14 · Cited by 60
Solanezumab: too late in mild Alzheimer's disease?
Neurology, T. L. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30395-7 · Cited by 58
Mazur‐Kolecka, B., Frackowiak, J., & Wísniewski, H. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00873-o · Cited by 57
The hypoxia–inflammation link and potential drug targets
Koeppen, M., Eckle, T. D. L. G., & Eltzschig, H. K. (2011) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e32834873fd · Cited by 57
Benzodiazepine receptors mediate regional blood flow changes in the living human brain.
Matthew, E. M., Andreason, P., Pettigrew, K. D., Carson, R. E., Herscovitch, P., Cohen, R. M., King, C., Johanson, C. E., Greenblatt, D. J., & Paul, S. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2775 · Cited by 57
Cerebral amyloid angiopathy and gene polymorphisms
Yamada, M. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.009 · Cited by 57
Verbeek, M. M., Nostrand, W. E. V., Otte‐Höller, I., Wesseling, P., & de Waal, R. M. W. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06368.x · Cited by 57
β amyloid angiogenic activity in vitro and in vivo
Boscolo, E., Folin, M., Nico, B., Grandi, C., Mangieri, D., Longo, V., Scienza, R., Zampieri, P., Conconi, M. T., Parnigotto, P., et al. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.19.4.581 · Cited by 56
Interaction with Amyloid β Peptide Compromises the Lipid Binding Function of Apolipoprotein E
Tamamizu‐Kato, S., Cohen, J. K., Drake, C. B., Kosaraju, M. G., Drury, J., & Narayanaswami, V. (2008) · Biochemistry · doi:10.1021/bi702097s · Cited by 56
Comparison between Alzheimer's disease and vascular dementia: Implications for treatment
Kalaria, R. N. (2003) · Neurological Research · doi:10.1179/016164103101201968 · Cited by 55
Stroke related to cerebral amyloid angiopathy: the significance of systemic vascular disease
Ferreiro, J. A., Ansbacher, L. E., & Vinters, H. V. (1989) · Journal of Neurology · doi:10.1007/bf00314454 · Cited by 55
ApoE in Atherosclerosis: A Protein With Multiple Hats
Curtiss, L. K. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.1852 · Cited by 55
Cited by
The interplay between diet and the gut microbiome: implications for health and disease
Ross, F. C., Patangia, D., Grimaud, G., Lavelle, A., Dempsey, E. M., Ross, R. P., & Stanton, C. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-024-01068-4 · Cited by 638
Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298
Neurovascular Unit Dysfunction and Neurodegenerative Disorders
Yu, X., Ji, C., & Shao, A. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00334 · Cited by 244
Alzheimer’s Disease: Exploring the Landscape of Cognitive Decline
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00339 · Cited by 170
Cummings, J. L., Atri, A., Feldman, H. H., Hansson, O., Sano, M., Knop, F. K., Johannsen, P., León, T., & Scheltens, P. (2025) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01666-7 · Cited by 168
Metadata
- Authors
- Govindpani, K., McNamara, L. G., Smith, N. R., Vinnakota, C., Waldvogel, H. J., Faull, R. L., & Kwakowsky, A.
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2019-05-10
- Volume
- 8
- Issue
- 5
- Pages
- 651
- ISSN
- 2077-0383 (ISSN-L)
- OpenAlex
- W2946791655
- Cited by
- 275
- References
- 471
- FWCI
- 13.00
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.